Valuation : Strides Pharma Science Limited

Market Cap 97.11B 1.03B 884M 829M 759M 1.42B 1.43B 9.81B 3.82B 49.63B 3.86B 3.77B 160B P/E 2027 *
15.5x
P/E 2028 * 11x
Enterprise Value 97.11B 1.03B 884M 829M 759M 1.42B 1.43B 9.81B 3.82B 49.63B 3.86B 3.77B 160B EV / Sales 2027 *
1.67x
EV / Sales 2028 * 1.4x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day+0.55%
1 week+7.18%
Current month+2.79%
1 month+2.44%
3 months-2.55%
6 months+26.51%
Current year+17.02%
1 week 982.1
Extreme 982.1
1,073
1 month 931.3
Extreme 931.3
1,073
Current year 768.65
Extreme 768.65
1,231
1 year 768.65
Extreme 768.65
1,231
3 years 440.5
Extreme 440.5
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 31/05/2024
Director of Finance/CFO 42 31/05/2024
Chief Tech/Sci/R&D Officer - 20/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 17/05/2017
Director/Board Member 82 17/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+7.18%+17.53%+137.22% 1.02B
-0.81%+0.14%+21.37%+72.78% 49.06B
+0.41%+0.12%+52.20%+121.38% 40.37B
-0.97%-3.88%+13.37%+84.21% 12.19B
-1.28%-1.78%-11.64%+12.58% 12.08B
+0.57%+0.95%+29.02%+153.11% 9.14B
+0.08%-4.12%+24.01%+43.45% 7.36B
-0.04%-0.04%+22.68%+222.92% 7.35B
+0.81%-0.04%+45.87%-10.06% 7.32B
+0.03%-1.75%-40.80%+14.39% 5.19B
Average -0.07%+0.41%+17.36%+85.20% 15.11B
Weighted average by Cap. -0.25%+0.41%+26.00%+87.03%

Financials

2027 *2028 *
Net sales 58.23B 616M 530M 497M 455M 849M 856M 5.88B 2.29B 29.76B 2.31B 2.26B 95.84B 69.12B 731M 629M 590M 540M 1.01B 1.02B 6.98B 2.72B 35.32B 2.75B 2.69B 114B
Net income 6.28B 66.41M 57.14M 53.62M 49.05M 91.56M 92.28M 634M 247M 3.21B 249M 244M 10.33B 8.8B 93.07M 80.08M 75.15M 68.75M 128M 129M 889M 346M 4.5B 349M 342M 14.48B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
03/09/26 1,053.60 +0.55% 189,318
02/09/26 ₹1,047.80 +2.30% 327,406
01/09/26 ₹1,024.20 -0.08% 200,361
31/08/26 ₹1,025.00 +0.50% 426,871
28/08/26 ₹1,019.90 +3.75% 435,651
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,053.60INR
Average target price
1,338.67INR
Spread / Average Target
+27.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock